Gates Capital Management’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.6M Buy
8,742,274
+2,483,625
+40% +$22.8M 1.89% 27
2026
Q1
$58.1M Sell
6,258,649
-2,126,885
-25% -$20.9M 1.59% 28
2025
Q4
$58.6M Sell
8,385,534
-2,514,918
-23% -$15.8M 1.54% 27
2025
Q3
$62.2M Sell
10,900,452
-1,893,489
-15% -$10.1M 1.11% 30
2025
Q2
$61.2M Buy
12,793,941
+3,637,019
+40% +$20.9M 1.05% 30
2025
Q1
$79.4M Buy
+9,156,922
New +$96M 1.56% 24

Other funds holding NEOG

Gates Capital Management's NEOG Position: Q2 2026 in Review

Gates Capital Management increased its Neogen (NEOG) stake by 40% in Q2 2026, buying an estimated $22.8M and bringing the position to 8,742,274 shares worth $78.6M. The position accounts for 1.89% of the portfolio, ranked #27.

Gates Capital Management first reported a position in NEOG in Q1 2025 and has held it in 6 quarters since. The position peaked at $79.4M in Q1 2025. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Gates Capital Management held 8,742,274 shares of Neogen worth $78.6M as of Q2 2026.
  • Gates Capital Management bought 2,483,625 Neogen shares in Q2 2026, an estimated $22.8M.
  • Neogen made up 1.89% of Gates Capital Management's portfolio in Q2 2026, its #27 holding.
  • Gates Capital Management first reported a position in Neogen in Q1 2025 and has held it in 6 quarters since.
  • Gates Capital Management's Neogen position peaked at $79.4M in Q1 2025.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Gates Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.